Petrus Thomas Adrianos van der Zande
Chairman
Thermo Fisher Scientific Inc.’s (“Thermo Fisher”, “we” or the “Company”) 4i Values of Integrity, Intensity, Innovation and Involvement are the foundation of our culture, guiding all interactions with our customers, suppliers, partners, communities, and each other. As the first of these values, Integrity reminds our colleagues to honor commitments, communicate openly and demonstrate the highest ethical standards. This includes a commitment to ensuring that our own operations and our supply chain respect human rights and fair labor practices, and uphold global standards for equal opportunities, the freedom to associate, as well as the elimination of modern slavery, human trafficking, and harmful or exploitative forms of child labor.
This statement is made pursuant to:
This statement constitutes our human rights and modern slavery transparency statement for the financial year ending 31 December 2024 and was approved by the Thermo Fisher Board of Directors on 20 May 2025. Our previous human rights and modern slavery statements are available in the “Corporate Social Responsibility” section of our website under the heading “Global Supply Chain,” which can be found here.
Thermo Fisher, as parent company of the Thermo Fisher group of companies (the “Group”), issues this statement on behalf of itself and each of its subsidiaries that are subject to each of the Acts, respectively, and in particular, its subsidiaries listed in Annexes I to V, which have conferred and collaborated in the preparation, review and finalization of this statement.
Thermo Fisher is the world leader in serving science. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences medicines, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD.
We report our business in four segments - Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services.
Our supply chain includes tens of thousands of suppliers globally. These suppliers provide the raw materials we use for manufacturing, services to support our research teams and the lab equipment, chemicals, and other vital goods used across our manufacturing and service network around the world. No single supplier is material, although for reasons of quality assurance, regulatory requirements, cost effectiveness, availability or uniqueness of design, certain materials and components may be sourced from a single supplier or a limited number of suppliers that can readily provide such materials or components.
For more information regarding our business, please see the “Business” section of our Annual Report on Form 10-K for the year ended 31 December 2024, which can be found here.
More information about our supply chain is available in the “Corporate Social Responsibility” section of our website under the heading “Global Supply Chain,” which can be found here.
As a signatory to the UN Global Compact (“UNGC”), Thermo Fisher is committed to aligning corporate strategy with the Ten Principles on human rights, labor, environment and anti-corruption and to the applicable laws and fair labor practices, as evidenced by the following Company policies:
These policies help us implement a human rights framework aligned with leading international standards, including the UN Universal Declaration of Human Rights and the International Labour Organization (“ILO”) Declaration on Fundamental Principles and Rights at Work. Our approach references the United Nations Guiding Principles on Business and Human Rights (“UNGP”) and the Organisation for Economic Co-operation and Development (“OECD”) Guidelines for Multinational Enterprises (“OECD Guidelines”).
When differences arise between our standards and legal requirements, we apply the stricter standard.
With the rapid evolution of technology, society’s needs, and stakeholder expectations, we continue to strengthen our policies and business processes for identifying, assessing and managing human rights risks, including by conducting periodic internal reviews of our systems and controls and participating in human rights peer networks for best practice sharing.
The Thermo Fisher Human Rights and Equal Opportunity Policy (the “Human Rights Policy”) outlines principles and commitments for the Company’s operations, which include the prohibition of forced labor, prison labor and trafficking in persons; prohibition of child labor; non-discrimination and equal opportunity; fair treatment; adequate wages, benefits and working hours; freedom of association; as well as healthy and safe work standards. It applies to all Thermo Fisher employees, contractors, agents, and other partners through whom Thermo Fisher conducts business.
The Thermo Fisher Code of Business Conduct and Ethics (the “Code of Conduct”) is translated into 21 languages and covers a broad range of topics, including policies related to conflicts of interest, honest and ethical fair dealing, bribery and improper payments, insider trading, export control awareness, human rights, privacy matters, respectful interactions at work and harassment. It applies to all Thermo Fisher employees and sets forth our commitment to conduct business with the highest ethical standards and to comply with all applicable laws and regulations. Violations are not tolerated and may lead to disciplinary action, up to and including termination.
The Thermo Fisher Supplier Code of Conduct (“Supplier Code”) outlines expectations for our suppliers/partners and their subcontractors in the areas of ethics, human rights, health and safety, environmental responsibility, and management systems. In 2024, we reviewed our Supplier Code to maintain expectations associated with local laws and regulations. These expectations are in line with our corporate values, the Code of Conduct and the UNGC’s Ten Principles, and include:
The Supplier Code is also integrated into supply agreements and terms and conditions, and suppliers are expected to share their performance against Supplier Code expectations at our request. Thermo Fisher reserves the right to take appropriate contractual measures up to and including contract termination where necessary and appropriate as outlined in the Supplier Code.
We encourage reporting and offer a number of resources for the reporting of illegal or unethical behavior in our operations or in our supply chain, such as our confidential Global Ethics Hotline (“Ethics Hotline”). The Ethics Hotline is our telephone and web-based hotline maintained by a third party for the purpose of gathering information regarding compliance and ethics concerns. It is available to colleagues, customers and other external stakeholders such as suppliers and workers in the supply chain, to raise concerns, anonymously if requested, related to any issue, observed or suspected, including human rights issues, and violation of any law, regulation, or any Company policies.
In addition, and in line with our company’s value of Integrity, anyone can report human rights- , ethics-, and compliance-related concerns directly to any level of internal leadership, as well as to Legal or Human Resources representatives.
Reports of violations of law, or any Company policies are rigorously investigated and documented.
Our non-retaliation policy ensures that retaliation against any person who lawfully and in good faith seeks advice, raises a concern, reports misconduct, or provides information in an investigation is strictly prohibited and will not be tolerated.
The Supplier Code also prohibits any supplier’s unlawful retaliation against its employees, including the threat of reprisal, intimidation, or harassment, for reporting violations or cooperating in investigations.
We have developed processes and management systems to appropriately identify and assess adverse impacts, prevent or mitigate these impacts or provide for remediation when appropriate, and track implementation, as informed by the OECD Due Diligence Guidance for Responsible Business Conduct (“OECD Guidance”).
In 2024, we continued oversight of our human rights management approach, via our designated Global Human Rights Counsel. The role has responsibility for leading the coordination of our legal human rights program across all businesses. This appointment strengthens awareness, compliance and adherence to governing principles and ethical and legal codes. The Global Human Rights Counsel reports to senior management on a regular basis.
During the year, we continued to enhance our human rights due diligence practices. This included in-depth human rights risk assessment of our operations and supplier network in compliance with regulatory requirements. Our assessments indicate that human rights risks, including forced and child labor risks, in our operations in the aggregate remain low. This is primarily due to our company-wide applicable standards, and the preventive and mitigating measures that we have implemented in our standard processes, such as comprehensive policies, employee training, personnel documentation checks, use of working time management systems, and environmental, health and safety (“EHS”) site audits and certifications. A new internal oversight process enables the company to more regularly monitor human rights-related matters, and continue to identify, assess and manage human rights risks.
We source components globally that are used both at our facilities and by our external partners to manufacture our products. With such a global structure, the supply chain is the main area where Thermo Fisher is at the highest risk for adverse human rights impacts.
Thermo Fisher expects suppliers to treat their employees with dignity and respect, to comply with all legal and regulatory requirements pertaining to the fair treatment of employees, and to proactively assess and monitor their subcontractors to ensure they abide by the same principles. We are committed to implementing effective systems and controls to ensure that our suppliers recognize our position in relation to compliance with all applicable laws and regulations.
Our risk-based approach to supplier engagement and monitoring allows us to focus our resources on areas that we believe have the largest potential impact. Our supply chain risk assessment starts with evaluating all suppliers based on geography and industry by risk ranking locations and industries where risks of labor, human rights, or environmental issues are generally highest. This risk assessment references external sustainability sources and indices including from WRI, WHO, UNDP, ILO, The World Bank and the Corruption Perception Index, as well as a large database of actual corporate performance on labor, human rights, and environmental topics. Globally, the percentage of our supply chain that falls into the highest risk portion of this assessment represents less than 1% of all suppliers.
Following this comprehensive process, we further seek to prioritize areas for direct supplier assessment. In 2024, we executed detailed supplier engagement initiatives focusing on suppliers who:
Human rights are integrated into our follow-on supplier due diligence process, where indicators such as the risk of child labor, the risk of modern slavery, the right of freedom of association, and the decency of working conditions are evaluated.
In 2024, Thermo Fisher utilized multiple mechanisms to conduct due diligence to evaluate and address modern slavery risks, such as third-party reviewed supplier assessments, including specific human rights assessments, and onsite auditing. These mechanisms allow us to monitor compliance with our Supplier Code and to assess and accelerate improvements in supplier practices.
Third-party assessments were conducted for the following targeted supplier populations:
Additionally, where suppliers who fall outside the targeted supplier populations voluntarily share the results of a supplier assessment completed for another customer, Thermo Fisher included such assessments in our program. For all assessments received in the previous 2 years (2023 and 2024), greater than 79% represented at least “good” management practice, and less than 1% were identified as having “insufficient” performance.
In all cases, where performance is deemed “insufficient” or “partial”, corrective action plans are requested from suppliers to drive continuous improvement. Thermo Fisher monitors these suppliers to confirm that the corrective action plans are implemented, and suppliers are reassessed in twelve months’ time. Suppliers who persistently refuse to participate or do not demonstrate continuous improvement are targeted for escalated engagement, potentially including a third-party, onsite audit.
Additionally, more specific supplier engagement was undertaken for additional investigation in the following areas:
Finally, for certain suppliers representing particularly high business risk, onsite audits, all of which were announced, were conducted by third-party independent auditors covering compliance, ethical trading, labor regulations and standards, and responsible production practices. Where onsite audits identified findings, corrective action plans were developed and mutually agreed upon between the Company and the supplier and follow-up activities were conducted to confirm issues were resolved. In all audits completed in 2024, no major findings were identified.
All employees globally receive compulsory annual training on the ethical and human rights principles and standards outlined in our Code of Conduct and the Human Rights and Equal Opportunity Policy. This training is offered in 21 languages and mapped to the regions where employees are based
As Thermo Fisher continually improves responsible procurement processes and champions suppliers’ sustainability initiatives, in 2024 we have advanced our education offerings, as follows:
Thermo Fisher also continued its work with the Sustainable Procurement Pledge, an international, non-profit organization for procurement professionals, academics, and practitioners, driving awareness and knowledge of responsible sourcing practices.
Thermo Fisher will continue to review and improve its practices to respect human rights for rightsholders affected by our business and identify and eliminate, to the fullest extent practicable, modern slavery, child labor or human trafficking from our business and supply chain. To maintain and continually improve our own operational and supply chain performance we:
An overview of select performance indicators organized around the pillars of our Corporate Social Responsibility strategy, including human rights topics, is available in the “Corporate Social Responsibility” section of our website, which can be found here. Our reporting includes a data summary section that provides a consolidated and historical view of these performance indicators, measuring the effectiveness of our efforts. Based on our efforts, including due diligence, we have no indication that our operations or those of our suppliers are negatively impacting human rights.
Our actions as described above support the Thermo Fisher long-term commitment to respect the human rights of all people and to improve the quality of life in the communities we serve.
Signed on behalf of Thermo Fisher Scientific Inc.
Marc N. Casper
Chairman, President, and Chief Executive Officer
All of the entities listed below are fully owned indirect subsidiaries of Thermo Fisher Scientific Inc. registered in Norway, and are considered Reporting Subsidiaries under the Norwegian Act:
All of Thermo Fisher’s Reporting Subsidiaries in Norway engage in sales, customer support, and marketing.
Thermo Fisher’s operations in Norway are located in Oslo and Lillestrom. As of December 31, 2024, these operations collectively employed approximately 330 colleagues, primarily within the Life Science Solutions segment.
Life Technologies AS primarily focuses on the research and development, manufacturing, and distribution of Dynabeads magnetic separation products.
Thermo Fisher Diagnostics AS specializes in in vitro diagnostics, including test kits, reagents, culture media, instruments, and associated products, to serve customers in healthcare, clinical, microbiological, pharmaceutical, and industrial laboratories.
Fisher Scientific AS serves biotech, pharmaceutical, academic, government, industrial, and healthcare customers by providing them with a range of products and services, including lab consumables, instruments and equipment, safety products, chemicals and life sciences reagents.
All Reporting Subsidiaries adhere to the Company’s policies and procedures and are subject to the risk management strategy detailed in this Transparency Statement, including due diligence, risk assessment of operations and supply chain, and all preventive and mitigating measures discussed herein. In addition to the activities described above, sites in Norway implemented a new supplier onboarding process that includes acknowledgement of the Supplier Code of Conduct, serving as an additional preventive measure to avoid risk in our supply chain.
Signed on behalf of Thermo Fisher’s Norwegian Reporting Subsidiaries pursuant to the Norwegian Transparency Act.
Petrus Thomas Adrianos van der Zande
Chairman
Anne Omholt
Director
Sara Maria Carrella
Director
Petrus Thomas Adrianos van der Zande
Chairman
Anne Omholt
Director
Carolin Sonja Freidel
Director